Investigating how methamphetamine use affects HIV and STI risk among men who have sex with men
Effects of methamphetamine use on risk behavior, systemic and mucosal inflammation, and sexually transmitted infection (STI)/HIV risk among men who have sex with men
This study is looking at how using methamphetamine affects the chances of getting HIV and other sexually transmitted infections in men who have sex with men, and it aims to find better ways to help prevent these risks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10841633 on NIH RePORTER |
What this research studies
This research focuses on understanding the impact of methamphetamine use on the risk of HIV and sexually transmitted infections (STIs) among men who have sex with men (MSM). It aims to explore both behavioral and biological factors that contribute to increased risk, utilizing a multidisciplinary approach that includes addiction medicine and applied immunology. The study will involve clinical trials and biobehavioral interventions to develop effective strategies for prevention. By examining the interplay between drug use, sexual behavior, and infection rates, the research seeks to inform better public health interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are men who have sex with men and are current or former users of methamphetamine.
Not a fit: Patients who do not use methamphetamine or do not engage in sexual activities with men may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies for HIV and STIs among at-risk populations.
How similar studies have performed: Previous research has shown that understanding the relationship between substance use and sexual risk behavior can lead to effective interventions, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Blair, Cherie Savine — University of California Los Angeles
- Study coordinator: Blair, Cherie Savine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.